|
DE4224534A1
(de)
*
|
1992-07-24 |
1994-01-27 |
Marika Dr Med Ehrlich |
Ovulationshemmendes Mittel zur hormonalen Kontrazeption
|
|
DE4313926A1
(de)
*
|
1993-04-28 |
1994-11-03 |
Jenapharm Gmbh |
Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
|
|
US6407082B1
(en)
*
|
1996-09-13 |
2002-06-18 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of a vitamin D compound
|
|
DE4321957C2
(de)
*
|
1993-07-01 |
1995-09-28 |
Marika Dr Med Ehrlich |
Verwendung eines hormonalen Mittels zur Therapie der Akne
|
|
DE4344405C2
(de)
*
|
1993-12-24 |
1995-12-07 |
Marika Dr Med Ehrlich |
Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
|
|
DE4405591C1
(de)
*
|
1994-02-22 |
1995-07-20 |
Hesch Rolf Dieter Prof Dr Med |
Mittel zur postmenopausalen Hormonsubstitution
|
|
DE4411585A1
(de)
*
|
1994-03-30 |
1995-10-05 |
Schering Ag |
Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
|
|
DE4429374C1
(de)
|
1994-08-12 |
1996-02-01 |
Jenapharm Gmbh |
Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
|
|
DE19504227C2
(de)
*
|
1995-02-09 |
1999-04-29 |
Klaus Dr Med Umbreit |
Ovulationshemmendes Mittel zur hormonalen Kontrazeption
|
|
DE19513662A1
(de)
*
|
1995-04-08 |
1996-10-10 |
Schering Ag |
Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
|
|
DE19540253C2
(de)
*
|
1995-10-28 |
1998-06-04 |
Jenapharm Gmbh |
Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
|
|
US20050032756A1
(en)
*
|
1995-10-28 |
2005-02-10 |
Michael Dittgen |
Multistage preparation for contraception based on natural estrogens
|
|
US5747480A
(en)
*
|
1996-05-08 |
1998-05-05 |
American Home Products Corporation |
Oral contraceptive
|
|
US5888543A
(en)
*
|
1996-07-26 |
1999-03-30 |
American Home Products Corporation |
Oral contraceptives
|
|
US6451778B1
(en)
|
1996-07-26 |
2002-09-17 |
Wyeth |
Oral contraceptive
|
|
US5858405A
(en)
*
|
1996-07-26 |
1999-01-12 |
American Home Products Corporation |
Oral contraceptive
|
|
AU3888697A
(en)
*
|
1996-07-26 |
1998-02-20 |
American Home Products Corporation |
Progestin/estrogen oral contraceptive
|
|
US6479475B1
(en)
|
1996-07-26 |
2002-11-12 |
Wyeth |
Oral contraceptive
|
|
US6034074A
(en)
|
1996-09-13 |
2000-03-07 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of a Vitamin D compound
|
|
US6028064A
(en)
|
1996-09-13 |
2000-02-22 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of progestin products
|
|
US6765002B2
(en)
|
2000-03-21 |
2004-07-20 |
Gustavo Rodriguez |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
|
|
US6511970B1
(en)
|
1996-09-13 |
2003-01-28 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
|
|
ATE279198T1
(de)
*
|
1997-08-27 |
2004-10-15 |
Ortho Mcneil Pharm Inc |
Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
|
|
US6251956B1
(en)
|
1998-08-20 |
2001-06-26 |
Ortho Pharmaceutical Corporation |
Combination progestin oral contraceptive regimen
|
|
US7459445B2
(en)
*
|
2000-03-10 |
2008-12-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and topical pharmaceutical formulations of the same
|
|
US6660726B2
(en)
|
2000-03-10 |
2003-12-09 |
Endeavor Pharmaceuticals |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
|
|
US7989436B2
(en)
|
2003-07-23 |
2011-08-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and pharmaceutical formulations comprising the same
|
|
US6855703B1
(en)
|
2000-03-10 |
2005-02-15 |
Endeavor Pharmaceuticals |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
|
|
US20040176336A1
(en)
*
|
2000-03-21 |
2004-09-09 |
Rodriguez Gustavo C. |
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
|
|
US20050113351A1
(en)
*
|
2000-03-21 |
2005-05-26 |
Rodriguez Gustavo C. |
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
|
|
US20010044431A1
(en)
*
|
2000-03-21 |
2001-11-22 |
Rodriguez Gustavo C. |
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
|
|
AU2002348272B2
(en)
*
|
2001-12-05 |
2008-07-31 |
Theramex HQ UK Limited |
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
|
|
US6992075B2
(en)
|
2003-04-04 |
2006-01-31 |
Barr Laboratories, Inc. |
C(14) estrogenic compounds
|
|
EP1622623A4
(en)
*
|
2003-04-11 |
2009-03-18 |
Barr Lab Inc |
METHOD FOR THE ADMINISTRATION OF ESTROGENIC AND TESTED
|
|
CN101001631B
(zh)
*
|
2003-07-16 |
2014-08-06 |
特卫华妇女健康有限公司 |
利用连续给予雌激素的避孕方案的激素治疗方法
|
|
DE102004019743B4
(de)
*
|
2004-04-20 |
2008-11-27 |
Bayer Schering Pharma Aktiengesellschaft |
Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
|
|
DE102004026669A1
(de)
*
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
|
|
DE102004026670A1
(de)
*
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
|
|
DE102004026671A1
(de)
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Darreichungsform zur hormonalen Kontrazeption
|
|
US20070111975A1
(en)
|
2004-10-07 |
2007-05-17 |
Duramed Pharmaceuticals, Inc. |
Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
|
|
US20060100566A1
(en)
*
|
2004-11-05 |
2006-05-11 |
Women's Medical Research Group, Llc |
Apparatus and method for the treatment of dysmenorrhea
|
|
WO2006084082A1
(en)
*
|
2005-02-03 |
2006-08-10 |
Duramed Pharmaceuticals, Inc. |
Compositions of unconjugated estrogens and methods for their use
|
|
US7704984B2
(en)
*
|
2005-04-22 |
2010-04-27 |
Warner Chilcott Company, Llc |
Extended estrogen dosing contraceptive regimen
|
|
US8153616B2
(en)
|
2005-10-17 |
2012-04-10 |
Bayer Pharma Aktiengesellschaft |
Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
|
|
EP1930010A1
(de)
|
2006-10-20 |
2008-06-11 |
Bayer Schering Pharma Aktiengesellschaft |
Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
|
|
CA2856520C
(en)
|
2011-11-23 |
2021-04-06 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
MX2016014281A
(es)
|
2014-05-22 |
2017-02-22 |
Therapeuticsmd Inc |
Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
|
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
|
MX2018011705A
(es)
|
2016-04-01 |
2019-06-10 |
Therapeuticsmd Inc |
Composicion farmaceutica de hormona esteroide.
|
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|